Home » Biotechnology » Yersinia Diagnostics Market

Yersinia Diagnostics Market – Growth, Future Prospects & Competitive Analysis, 2018-2026

Published: | Report ID: 11937 | Report Format : PDF

Market Insights

Yersinia is a gram-positive bacteria that causes terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, northern Europe, and Scandinavia, making these regions the largest markets for Yersinia diagnostics. Furthermore, greater adoption of novel molecular diagnostic tools and higher awareness also contribute to the dominance of these markets. On the other hand, the Asia-Pacific Yersinia diagnostics market holds great potential due to the wide presence of untapped opportunities in emerging Asian countries and the significantly high prevalence of Yersinia infection in Japan.

Treatment of Yersinia infections includes drugs such as aminoglycosides, cephalosporins, tetracyclines, trimethoprim-sulfamethoxazole (TMP-SMZ), and fluoroquinolones. The diagnostic methods used include ELISA, tube agglutination, radioimmunoassay, ultrasonography, stool culture, CT scan, and colonoscopy, among others. Definitive detection of Yersinia enterocolitica isolates can also be performed through the sequencing of the 16S rRNA gene. An immunoblot with plasmodial encoded Yersinia protein also enables serological identification. However, the development of more sensitive, efficient, and yet simple, rapid diagnostic systems that can be applied to direct and indirect diagnosis still remain a challenge in this market.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

The global Yersinia diagnostics market is segmented on the following basis:

Test Type

  • Stool Culture
  • ELISA
  • Radioimmunoassay
  • Tube Agglutination
  • CT Scan
  • Ultrasonography
  • Colonoscopy

Technology

  • DNA Probes
  • Immunoassay
  • Monoclonal Antibodies
  • PCR
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Key players identified for the Yersinia diagnostics market include but are not limited to:

Abbott Laboratories, Inc., Hologic, F. Hoffmann-La-Roche, Becton Dickinson, Danaher Corporation, Bio-Rad Laboratories, Affymetrix, Inc., Thermo Fisher Scientific, and others

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

This report offers the following:

  • An analysis of several techniques, test types, and regions that would provide a clear understanding of the ongoing and future trends in the global Yersinia diagnostics market
  • Assessment of market dynamics, such as drivers, restraints, and opportunities prevalent in the market
  • Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
  • Company profiles that will highlight key information about the imperative players operating in the global Yersinia diagnostics market

Frequently Asked Questions:

What is the size of Yersinia Diagnostics Market?

The market for Yersinia Diagnostics Market is expected to reach US$ XX Mn By 2026.

What is the Yersinia Diagnostics Market CAGR?

The Yersinia Diagnostics Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Yersinia Diagnostics Market?

The report is forecasted from 2018-2026.

What is the base year considered for Yersinia Diagnostics Market?

The base year of this report is 2017.

Who are the major players in this market?

Abbott Laboratories, Inc., Hologic, F. Hoffmann-La-Roche, Becton Dickinson, Danaher Corporation, Bio-Rad Laboratories, Affymetrix, Inc., Thermo Fisher Scientific are some of the major players in the global market.

Viral Antigens Market

Published:
Report ID: 36114

Recombinant Protein Market

Published:
Report ID: 35991

Bacteriophage Market

Published:
Report ID: 2114

India Bone Marrow Transplantation (BMT) Market

Published:
Report ID: 35571

Bioengineered Skin And Skin Substitutes Market

Published:
Report ID: 3472

DNA and RNA Sample Preparation Market

Published:
Report ID: 34911

Laboratory Filtration Market

Published:
Report ID: 7940

Adult Hemoglobinopathy Testing Market

Published:
Report ID: 34717

Nanobiotechnology Market

Published:
Report ID: 14350

Canine Stem Cell Therapy Market

Published:
Report ID: 34386

Humanized Mice Model Market

Published:
Report ID: 34329

Mobile Water Treatment Systems Market

Published:
Report ID: 19203

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN